ArticlePDF Available

Influence of nutritional status and gastrointestinal symptoms on sleep quality in people living with HIV

Authors:

Abstract and Figures

Sleep problems are frequent among people living with HIV (PLWH). Recent studies have found that inadequate nutritional status and presence of gastrointestinal symptoms are associated with sleep problems. Therefore, the objective of the present study was to evaluate the influence of nutritional status and gastrointestinal symptoms on sleep quality in PLWH receiving antiretroviral therapy (ART). A cross-sectional study evaluating the influence of nutritional and gastrointestinal aspects on the quality of sleep in 307 PLWH (age ≥18 years) receiving ART seen at the Specialized Care Service of Santos (SP, Brazil) was carried out. The Pittsburgh Sleep Quality Index (PSQI), body mass index and three questions from the Self-Reporting Questionnaire (SRQ-20) were used. Generalized linear models adjusted for gender, age, time in use of antiretrovirals, viral load, CD4+ T-lymphocyte cell count and CD4/CD8 ratio were built. Results showed that body mass index did not affect sleep quality. However, the interaction between poor appetite and not having poor digestion and uncomfortable feelings in the stomach negatively influenced sleep quality. The interaction of the three symptoms evaluated also affected sleep quality. Gastrointestinal symptoms were associated with reduced sleep quality, but there was no influence of BMI. Although the etiology of this relationship is unclear, there seems to be an important association between sleep quality, immune function and gastrointestinal disorders.
Content may be subject to copyright.
Original research article
Influence of nutritional status and
gastrointestinal symptoms on sleep
quality in people living with HIV
Luciana Fidalgo Ramos Nogueira
1
, Thais Carvalho da Fonseca
1
,
Patrick Herman Paterlini
1
, Adriana de Sousa Duarte
1
,
Pollyanna Pellegrino
1
, Claudia Renata dos Santos Barros
1
,
Claudia Roberta de Castro Moreno
2
and
Elaine Cristina Marqueze
1
Abstract
Sleep problems are frequent among people living with HIV (PLWH). Recent studies have found that inadequate
nutritional status and presence of gastrointestinal symptoms are associated with sleep problems. Therefore, the objec-
tive of the present study was to evaluate the influence of nutritional status and gastrointestinal symptoms on sleep
quality in PLWH receiving antiretroviral therapy (ART). A cross-sectional study evaluating the influence of nutritional and
gastrointestinal aspects on the quality of sleep in 307 PLWH (age 18 years) receiving ART seen at the Specialized Care
Service of Santos (SP, Brazil) was carried out. The Pittsburgh Sleep Quality Index (PSQI), body mass index and three
questions from the Self-Reporting Questionnaire (SRQ-20) were used. Generalized linear models adjusted for gender,
age, time in use of antiretrovirals, viral load, CD4þT-lymphocyte cell count and CD4/CD8 ratio were built. Results
showed that body mass index did not affect sleep quality. However, the interaction between poor appetite and not
having poor digestion and uncomfortable feelings in the stomach negatively influenced sleep quality. The interaction of
the three symptoms evaluated also affected sleep quality. Gastrointestinal symptoms were associated with reduced sleep
quality, but there was no influence of BMI. Although the etiology of this relationship is unclear, there seems to be an
important association between sleep quality, immune function and gastrointestinal disorders.
Keywords
Human immunodeficiency virus, sleep-wake disorders, nutritional status, gastrointestinal tract
Date received: 1 November 2018; Revised received 3 April 2019; accepted: 4 April 2019
Introduction
Of the 36.7 million people worldwide living with HIV
in 2016, 53% were on antiretroviral therapy (ART).
In Brazil, also in 2016, despite the free distribution of
medications for HIV treatment by the Unified Health
System (SUS) since 1996, only 62% of the 649,000
people living with HIV (PLWH) were on ART.
1
Among the factors related to the prevalence of ART
use are its adverse effects, which cause physical and
metabolic changes that have been described as risk fac-
tors for chronic diseases.
2
Unlike in the era before
ART, when opportunistic infections were the main
cause of death of PLWH, this population currently
has a higher prevalence of cardiovascular diseases,
dyslipidemias, diabetes and non-AIDS cancers, when
compared to the general population.
3
These changes
also include inadequacy of nutritional status and
1
Department of Epidemiology, Public Health Graduate Program, Catholic
University of Santos, S~
ao Paulo, Brazil
2
Department of Health, Life Cycles and Society, School of Public Health,
University of S~
ao Paulo, S~
ao Paulo, Brazil
Corresponding author:
Elaine Cristina Marqueze, Department of Epidemiology, Public Health
Graduate Program, Catholic University of Santos, 300 Conselheiro
Ne
´bias Avenue, Santos, S~
ao Paulo 11015-001, Brazil.
Email: elaine.marqueze@unisantos.br
International Journal of STD & AIDS
0(0) 1–6
!The Author(s) 2019
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0956462419846723
journals.sagepub.com/home/std
gastrointestinal symptoms which, in turn, are associat-
ed with poor adherence to ART and HIV progression
to AIDS.
4
With regard to nutritional status, inadequacy is
associated with the pro-inflammatory environment of
HIV infection. Currently, the most important altera-
tions in PLWH are being overweight and obesity.
5
Gastrointestinal symptoms, as well as being overweight
and obesity, may be associated with the occurrence of
sleep problems among adults living with HIV.
Difficulties falling asleep and daytime sleepiness are
the main complaints reported, and both of these prob-
lems persist even in situations of viral replica-
tion control.
6
Sleep architecture is organized in cycles in which
NREM (non-rapid eye movement) and REM (rapid
eye movement) stages alternate successively and
repeat five to seven times per sleep session.
7
This orga-
nization, however, can be altered by factors such as
diseases and medication use, impairing cognitive capac-
ity, memory consolidation and immune function.
9
It is noteworthy that the presence of sleep disorders
is associated not only with chronic diseases, but also
with risk factors for their development, such as smok-
ing, alcoholism and inadequate eating habits.
10
In addi-
tion, it is a bidirectional relationship, since chronic
diseases may cause changes in the sleep-wake cycle,
with consequent impacts on physical and mental recov-
ery. Thus, the presence of gastrointestinal symptoms
and changes in body weight are also strongly associated
with poor sleep quality.
6
PLWH experience significant changes in sleep
patterns after infection, especially reduction in total
sleep time, increased sleep fragmentation due to fre-
quent awakenings, increased latency and poor sleep
quality.
11,12
These modifications may occur due to
pain, gastrointestinal disorders and respiratory prob-
lems.
13
In a systematic review performed by Low
et al.,
14
prevalence of poor sleep quality in PLWH
ranged from 29 to 97%, much higher than the 33%
prevalence estimated for the general population. This
broad range was due to the different evaluation meth-
ods, which ranged from subjective questionnaires to
polysomnography. However, many of the studies that
evaluated the occurrence of sleep problems among
PLWH were carried out more than 10 years ago, with
different ART regimens.
15
Therefore, the objective of the present study was to
evaluate the influence of nutritional status and gastroin-
testinal symptoms on sleep quality in PLWH on ART.
Methods
The study population consisted of 2000 PLWH on
ART aged 18 years, seen at the Specialized Care
Service (SAE) in the city of Santos (SP, Brazil) in
2014. The sample was calculated in 2014, the year in
which the proposal was submitted to the funding
agency. The data collection took place in 2016, after
approval of both the proposal and the project by the
ethics committee.
Based on a prevalence of poor sleep quality of 29%,
a generalized linear model test with a significance level
of 5%, sample error of 0.05 and assuming variations of
5% and loss of 10%, the selected sample comprised
322 patients (G*Power). Fifteen questionnaires, which
were either incomplete or inconsistent, were excluded,
giving a final sample of 307 PLWH.
The questionnaire was applied between February
and June 2016 in the form of an interview conducted
by trained graduate students. Data for the biochemical
indicators were obtained from the Control System for
Laboratory Tests of CD4/CD8 and Viral Load (Siscel,
a computer system managed by the Ministry of
Health). Only the results of the exams closest to the
interview date of each participant were used, and the
range of time did not exceed six months. This range
was established based on the Clinical Protocol and
Therapeutic Guidelines for Management of HIV
Infection in Adults,
13
which recommends that the bio-
chemical indicators for monitoring PLWH in clinical
follow-up should be performed every six months.
The dependent variable was sleep quality, assessed
by the validated Brazilian Portuguese version of the
Pittsburgh Sleep Quality Index (PSQI). Individuals
who obtained a global PSQI >5 were classified as
having poor sleep quality.
16
The independent variables were nutritional status
and gastrointestinal symptoms. Nutritional status was
assessed by the body mass index (BMI), obtained from
self-reported weight and height. It is important to
emphasize that the participants were interviewed on
the same day as their monthly medical visit at the
SAE, and that their weight was also measured. These
measures are considered valid and accurate for cross-
sectional epidemiological studies.
17
BMI score was
classified as underweight (<18.5 kg/m
2
), normal
(18.5–24.9 kg/m
2
), overweight (25.0–29.9 kg/m
2
)or
obese (30.0 kg/m
2
).
18
Gastrointestinal symptoms were assessed by three
questions taken from the validated version of the
Self-Reporting Questionnaire (SRQ-20).
19
The ques-
tions were: “Do you have uncomfortable feelings in
the stomach?”, “Do you have poor appetite?” and
“Do you have poor digestion?”
The normality of the variables was tested by the
Shapiro–Wilk test. The internal consistency and reli-
ability of the PSQI were determined by Cronbach’s
Alpha (p ¼0.70). Initially, the generalized linear
model (GLM) was built to evaluate the relationship
2International Journal of STD & AIDS 0(0)
between sleep quality and each independent variable
(BMI, uncomfortable feelings in the stomach, poor
appetite and poor digestion). Subsequently, a multiple
model was constructed that included only statistically
significant independent variables (p <0.05). All models
used gender, age, time in use of ART, viral load quan-
tification, CD4 lymphocyte cell count and CD4/CD8
ratio as covariates. The significance level for all tests
was 5%. Statistical analyses were performed using the
Statistica 7.0 and Stata 12.0 software packages.
Ethical issues related to human research were fully
respected and participants provided written informed
consent. The study was authorized by the Municipal
Health Department of Santos and approved by the
Research Ethics Committee of the Catholic
University of Santos (number 1.237.142).
Results
Participants had a mean age of 48 years (SD 12.1 years)
and 52.4% were female. Regarding gender, 59.4%
identified themselves as women. Most subjects had con-
cluded high school (50.5%), had no partner (73.0%)
and no paid work activity (60.3%). Mean time since
HIV diagnosis was 12.9 years (SD 8.1 years) and 95.8%
were on ART for an average of 9.4 years (SD
7.6 years). Concerning biochemical indicators, 71.4%
had undetectable viral load (<50 copies/mL), 89.7%
had CD4 lymphocyte cell count 200 cells/mm
3
and
73.3% had CD4/CD8 ratio <1.0.
Of the total number of participants, 49.5% had poor
sleep quality. Regarding gastrointestinal symptoms,
32.8% reported uncomfortable feelings in the stomach,
30.6% had poor appetite and 23.4% poor digestion.
Almost a third of the sample was classified as overweight
(30.5%), and 14.3% as obese. Only 20.7% reported
changes in body weight after HIV diagnosis. Of these,
14.5% reported a median loss of 12.5 kg (IQR 8.5–
20.0 kg) and 5.6% had a median gain of 11.0 kg (IQR
5.0–19.0 kg). However, 47.1% reported weight changes
over the preceding 12 months, of which 30.3% had a
median loss of 6.0 kg (IQR 3.0–12.0 kg) and 16.8% had
a median gain of 6.0 kg (IQR 3.0–12.0 kg).
Nutritional status did not influence sleep quality
(F ¼1.404 and p ¼0.237). By contrast, all three gastro-
intestinal symptoms negatively influenced sleep quality
(Figure 1). The multiple model revealed an interaction
effect between poor appetite and poor digestion on
those who had poor sleep quality (Figure 2(a)), and
between poor appetite and uncomfortable feelings in
the stomach, on poor sleep quality (Figure 2(b)).
(a) (b)
(c)
F=32.467 p< 0.001
Vertical bars represent 95 % CI
seYoN
Poor appetite
-5
0
5
10
15
PSQI score
F=8.4973 p= 0.004
Verti cal bars repres ent 95% C I
seYoN
Poor digestion
-5
0
5
10
15
PSQI sco re
F=18.385 p< 0.001
Vertical bars represent 95% CI
seYoN
Uncomf ort able feelin
g
s in the stomach
-5
0
5
10
15
PSQI score
Figure 1. Generalized linear models of gastrointestinal symptoms and sleep quality of PLWH. (a) ; (b) ; (c) .
Nogueira et al. 3
F=4.8575 p= 0.028
Vertical bars rep resent 9 5% CI
Poor digestion: no
Poor digestion: yes
seYoN
Poor app etite
-5
0
5
10
15
PSQI score
F=4.8606 p= 0.028
Vertical bars represent 95% CI
Uncomfortable feelings inthestomach: no
Uncomfort able feelings in the st omach: y es
seYoN
Poor appetite
-5
0
5
10
15
PSQI score
F=0.4450 p =0.505
Verti cal b ars repr esent 95% C I
Uncomfortable feelings in the stomach: no
Uncomfortable feelings in the stomach: yes
seYoN
Poor digestion
-5
0
5
10
15
PSQI score
F=4.0309 p =0.046
Vertical bars represent 95% CI
Poor digestion: no
Poo r di
g
estion:
y
es
Uncomfortable feelings in the stomach:
no
No Yes
-5
0
5
10
15
PSQI score
Uncomfortable feelings in the stomach:
yes
No Yes
Poor appetite Poor appetite
(a) (b)
(c)
(d)
Figure 2. Multiple model of gastrointestinal symptoms and sleep quality of PLWH. (a) ; (b) ; (c) ; (d) .
4International Journal of STD & AIDS 0(0)
There was no interaction effect of poor digestion and
uncomfortable feelings in the stomach on sleep quality
(Figure 2(c)). In addition, there was an interaction
between poor appetite, uncomfortable feelings in the
stomach and poor digestion, as well as an interaction
between poor appetite, uncomfortable feelings in the
stomach and no poor digestion, on those who had
poor sleep quality (Figure 2(d)).
Discussion
In the present study, regardless of gender, age,
time in use of ART, viral load quantification, CD4
T-lymphocyte cell count or CD4/CD8 ratio, the pres-
ence of gastrointestinal symptoms was associated with
worse sleep quality in PLWH. Although the etiology of
this relationship is not yet fully understood, there seems
to be an important association between sleep, immune
function and gastrointestinal disorders.
20
Persistent
inflammation, which is caused by HIV and can also
be induced by long-term use of ART, promotes chronic
activation of the immune system. One of the mecha-
nisms involved in this process is the homeostatic imbal-
ance of lymphoid tissue associated with the intestine.
4
Although the present study did not observe differences
related to the immune system and time in use of ART,
it is important to emphasize that sleep problems regu-
late and are regulated by cytokines which contribute to
chronic inflammation and, consequently, to gastroin-
testinal tract impairment.
21
No previous studies associating nutritional status
with sleep quality in this population were found.
However, in the study conducted by Lee et al.
22
inves-
tigating sleep problems in adults living with HIV,
no association was found between sleep fragmentation
and anthropometry. This result suggests, according to
the authors, that factors other than body weight may
play a more critical role in determining the sleep quality
in PLWH, as evidenced in the present study.
In the current HIV epidemic situation, however, it is
noteworthy that being overweight and obesity repre-
sent the main nutritional status among PLWH.
5
Furthermore, previous studies found similar prevalence
of being overweight and obesity both among ART-
naı
¨ve and PLWH who had been on treatment for
more than 10 years.
3,23,24
These data indicate that its
development can be accelerated and exacerbated by
factors independent of ART, which include inadequate
lifestyle and poor sleep quality.
4,25
The results of the present study are corroborated by
other authors who report a high prevalence of poor
sleep quality,
6,11,26,27
being overweight and greater pre-
disposition to the development of gastrointestinal
symptoms in PLWH.
5,28
Since the advent of ART, HIV infection has
assumed the characteristics of a chronic disease.
Complex life changes, imposed by both the disease
and the treatment, highlight the importance of non-
pharmacological interventions as an integral part of
the clinical follow-up of PLWH. Gastrointestinal dis-
orders and sleep problems in this population are often
underdiagnosed and inadequately treated. In this con-
text, comprehensive healthcare and sleep assessment by
specialized care services can contribute significantly to
better clinical outcomes.
Conclusion
Gastrointestinal symptoms were associated with
reduced sleep quality, but there was no influence of
BMI. The results highlight the importance of complete
nutritional assessment of PLWH which, in addition to
determining nutritional status, should also include
counseling for gastrointestinal symptoms reported by
patients. These measures can contribute more effective-
ly to the prevention and treatment of adverse effects
associated with HIV infection and ART, and conse-
quently promote better sleep and quality of life in
this population.
Acknowledgements
The authors extend thanks to the Municipal Health
Department of Santos Department of Surveillance
Coordination of Control of Infectious Diseases, for support-
ing the research, and to all the volunteers who participated in
the study for their valuable contribution.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of
this article.
Funding
This study was supported by the National Council for
Scientific and Technological Development CNPq (grant
number 455046/2014–0).
ORCID iD
Elaine Cristina Marqueze https://orcid.org/0000-0002-
4987-7757
References
1. Brazil. Ministry of health. AIDS and DST epidemiologic
bulletin. Bras
ılia: Ministry of Health, 2017, www.aids.
gov.br/pt-br/pub/2017/boletim-epidemiologico-hivaids-
2017 (accessed 29 June 2018).
2. Rodovalho AG, Trist~
ao FN, Galv~
ao LLC, et al.
Association between the use of antiretrovirals in HIV
Nogueira et al. 5
treatment and physical and metabolic alterations. Bluch
Educ Proc 2017; 2: 16–27.
3. Schouten J, Wit FW, Stolte IG, et al. Cross-sectional
comparison of the prevalence of age-associated comor-
bidities and their risk factors between HIV-infected and
uninfected individuals: the AGEhIV cohort study. Clin
Infect Dis 2014; 59: 1787–1797.
4. Tasca KI. Markers of immune activation,chronic inflam-
mation and oxidative stress in people living with HIV/
AIDS: searching for a better prognosis. PhD Thesis,
University of S~
ao Paulo, Brazil, 2016.
5. Santo RE, Grinsztejn B, Peres WAF, et al. Bioimpedance
and anthropometry in determining body composition in
HIV men. Rev Bras Nutr Clin 2016; 31: 60–64.
6. Allavena C, Guimard T, Billaud E, et al. Prevalence and
risk factors of sleep disturbance in a large HIV-infected
adult population. AIDS Behav (Behav) 2015; 20: 339–344.
7. Golem DL, Martin-Biggers JT, Koenings MM, et al. An
integrative review of sleep for nutrition professionals.
Adv Nutr 2014; 5: 742–759.
8. Neves GSL, Giorelli AS, Florido P, et al. Sleep disorders:
overview. Rev Bras Neurol 2013; 49: 57–71.
9. Watson NF, Badr MS, Belenky G, et al. Joint consensus
statement of the American Academy of Sleep Medicine
and Sleep Research Society on the recommended amount
of sleep for a healthy adult: methodology and discussion.
Sleep 2015; 38: 1161–1183.
10. Ulhoˆ a MA, Marqueze EC, Burgos LGA, et al. Shift work
and endocrine disorders. Int J Endocrinol 2015;
2015: 826249.
11. Crum-Cianflone NF, Roediger MP, Moore DJ, et al.
Prevalence and factors associated with sleep disturbances
among early-treated HIV-infected persons. Clin Infect
Dis 2012; 54: 1485–1494.
12. Colten HR, Altevogt BM and Committee on Sleep
Medicine and Research, Board on Health Sciences
Policy. Sleep disorders and sleep deprivation: an unmet
public health problem. Washington: The National
Academies Press, 2006.
13. Ministry of Health Brazil. Clinical protocol and thera-
peutic guidelines for management of HIV infection in
adults. Bras
ılia: Ministry of Health, 2013. Actualized in
July 2015, www.aids.gov.br/pt-br/pub/2013/protocolo-
clinico-e-diretrizes-terapeuticas-para-manejo-da-infec
cao-pelo-hiv-em-adultos (accessed 2 October 2018).
14. Low Y, Goforth H, Preud’homme X, et al. Insomnia in
HIV-infected patients: pathophysiologic implications.
AIDS Rev 2014; 16: 3–13.
15. Taibi DM, Price C and Voss J. A pilot study of sleep
quality and rest-activity patterns in persons living with
HIV. J Assoc Nurses AIDS Care 2013; 24: 411–421.
16. Buysse DJ, Reynolds CF, Monk TH, et al. The
Pittsburgh Sleep Quality Index: a new instrument for psy-
chiatric practice and research. Psychiatry Res 1989;
28: 193–213.
17. Dekkers JC, Van Wier MF, Hendriksen IJ, et al.
Accuracy of self-reported body weight, height and waist
circumference in a Dutch overweight working popula-
tion. BMC Med Res Methodol 2008; 8: 69.
18. World Health Organization. BMI classifications. Geneva:
World Health Organization, 2006, http://apps.who.int/
bmi/index.jsp?introPage¼intro_3.html (accessed 29
June 2018).
19. Gonc¸ alves DM, Stein AT and Kapczinski F.
Performance of the Self-Reporting Questionnaire as a
psychiatric screening questionnaire: a comparative
study with Structured Clinical Interview for DSM-IV-
TR. Cad Saude P ublica 2008; 24: 380–390.
20. Ji Y, Zhang F, Zhang R, et al. Changes in intestinal
microbiota in HIV-1-infected subjects following cART
initiation: influence of CD4þT cell count. Emerg
Microbes Infect 2018; 7: 113.
21. Ali T, Choe J, Awab A, et al. Sleep, immunity and
inflammation in gastrointestinal disorders. World J
Gastroenterol 2013; 19: 9231–9239.
22. Lee KA, Gay C, Portillo CJ, et al. Types of sleep prob-
lems in adults living with HIV/AIDS. J Clin Sleep Med
2012; 8: 67–75.
23. Silva EFR, Lewi DS, Vedovato GM, et al. Nutritional
and clinical status and dietary patterns in individuals
living with HIV/AIDS in outpatient care in Sao Paulo,
Brazil. Rev Bras Epidemiol 2010; 13: 1–12.
24. Kroll AF, Sprinz E, Leal SC, et al. Prevalence of obesity
and cardiovascular risk in patients with HIV/AIDS in
Porto Alegre, Brazil. Arq Bras Endocrinol Metabol
2012; 56: 137–141.
25. Mussini C, Lorenzini P, Cozzi-Lepri A, et al. CD4/CD8
ratio normalisation and non-AIDS-related events in indi-
viduals with HIV who achieve viral load suppression with
antiretroviral therapy: an observational cohort study.
Lancet HIV 2015; 2: e98–106.
26. Dabaghzadeh F, Khalili H, Ghaeli P, et al. Sleep quality
and its correlates in HIV positive patients who are can-
didates for initiation of antiretroviral therapy. Iran J
Psychiatry 2013; 8: 160–164.
27. Wu HS, Lu PL, Lin WC, et al. Sleep quality, depression,
anxiety, and self-esteem in people living with HIV/AIDS
(PLWHA). Hu Li Za Zhi 2017; 64: 34–44.
28. Pinto AF, Kauffmann LKO, Penha HPS, et al.
Nutritional status and gastrointestinal disorders in hos-
pitalized patients with HIV/AIDS at the Hospital
Universita
´rio Jo~
ao de Barros Barreto in Bele
´m, Para
´
State, Brazil. Rev Pan-Amaz Saude 2016; 7: 47–52.
6International Journal of STD & AIDS 0(0)
... The third antecedent, physical symptoms, includes fatigue (Chenxi et al., 2019;Han et al., 2021;Voss et al., 2021), pain (Nogueira et al., 2019;Redman et al., 2018;Sabin et al., 2020), apnea Gutierrez et al., 2019), gastrointestinal symptoms (Nogueira et al., 2019), and nocturnal sweats (Thorarinsdottir et al., 2019). The fourth antecedent of sleep disturbance is the side effects of the ARV therapy (González-Tomé et al., 2018;Ren et al., 2018;Shikuma et al., 2018;Venkataraman et al., 2021), and the fifth antecedent is social factors, including family and social support (Bedaso et al., 2020;Ren et al., 2018), internalized HIV stigma (Fekete et al., 2018), unsatisfactory lifestyles (dos Santos et al., 2018), low-income (Yan et al., 2021), unemployment (Najafi et al., 2021), and behavioral risk factors (Costa et al., 2019;Downing et al., 2020;Ogunbajo et al., 2020). ...
... The third antecedent, physical symptoms, includes fatigue (Chenxi et al., 2019;Han et al., 2021;Voss et al., 2021), pain (Nogueira et al., 2019;Redman et al., 2018;Sabin et al., 2020), apnea Gutierrez et al., 2019), gastrointestinal symptoms (Nogueira et al., 2019), and nocturnal sweats (Thorarinsdottir et al., 2019). The fourth antecedent of sleep disturbance is the side effects of the ARV therapy (González-Tomé et al., 2018;Ren et al., 2018;Shikuma et al., 2018;Venkataraman et al., 2021), and the fifth antecedent is social factors, including family and social support (Bedaso et al., 2020;Ren et al., 2018), internalized HIV stigma (Fekete et al., 2018), unsatisfactory lifestyles (dos Santos et al., 2018), low-income (Yan et al., 2021), unemployment (Najafi et al., 2021), and behavioral risk factors (Costa et al., 2019;Downing et al., 2020;Ogunbajo et al., 2020). ...
Article
Full-text available
Due to the differing definitions of the concept of sleep disturbance among people living with human immunodeficiency virus (HIV), reviewers in this area have not reached any firm conclusions. The study aimed to clarify and provide a stronger foundation for the definition of sleep disturbance in the context of HIV to enhance the concept’s development. Following Beth Rodgers’ concept analysis guidelines, two leading databases were searched, and 73 articles were used for this concept analysis. The attributes, surrogate terms, antecedents, and consequences of sleep disturbance have been identified using thematic analysis. In this analysis, two main attributes of sleep disturbance in the context of HIV were identified: a) subjective measures, including reduced total sleep time, difficulty falling asleep, nighttime and early morning awakenings, feeling sleepy and poorly rested after a night’s sleep, frequent arousals, and irritability, and b) objective measures, including changes in sleep architecture and sleep continuity. Five antecedents of sleep disturbance in the context of HIV were identified. Meanwhile, the consequences of sleep disturbance in HIV are listed based on the frequency the points occur within the reviewed articles. The list is as follows: fatigue and pain; reduced neurocognitive functions; reduced health outcome and quality of life; poor anti-retroviral (ARV) therapy adherence; daytime sleepiness; depression, anxiety, and maladaptive coping; increased disease progression and cardiovascular mortality; and social phobia, living arrangement and sexual dysfunction. An improved understanding of sleep disturbance in the context of HIV will be beneficial in directing analysts to develop research plans. At the same time, the knowledge gaps identified in the analysis provided a solid basis for further study intending to fill in these gaps.
... The highest covariances were found between the physical symptoms dimension and the dimensions of emotional distress, sleep/fatigue, and cognitive problems. Several studies have found relationships between these issues (Muñoz-Moreno et al., 2014;Tedaldi et al., 2015;Uebelacker et al., 2015;Allavena et al., 2016;Redman et al., 2018;Ren et al., 2018;Nogueira et al., 2019;Sabin et al., 2020). The size of the covariances suggests that these four dimensions could be grouped in a second-order latent dimension that encompasses physical, emotional and cognitive concerns. ...
Article
Full-text available
Background Numerous health-related issues continue to undermine the health and health-related quality of life (HRQoL) of people living with HIV (PLHIV). We developed a clinic screening tool (CST-HIV) for the purpose of identifying these issues in routine specialist clinical care in Spain. Methods We used the following established instrument development procedures: (1) a literature review; (2) four focus group discussions (FGDs), two that convened 16 expert HIV care providers, and two that convened 15 PLHIV; (3) prioritisation, selection and definition of constructs (health-related issues) to include in the CST-HIV and drafting of initial item pool; and (4) a pilot study to analyse psychometric properties and validity of items and to determine which to retain in the final CST-HIV. The FGD interview scripts incorporated an exercise to prioritise the health-related issues perceived to have the greatest negative effect on HRQoL. The online questionnaire used for the pilot study included the pool of CST-HIV items and validated measures of each construct. Results We identified 68 articles that reported on factors associated with the HRQoL of PLHIV. The most burdensome health-related issues identified in the FGDs related to stigma, socioeconomic vulnerability, sleep/fatigue, pain, body changes, emotional distress, and sexuality. Based on the literature review and FGD findings, we selected and defined the following constructs to include in the initial CST-HIV: anticipated stigma, emotional distress, sexuality, social support, material deprivation, sleep/fatigue, cognitive problems, and physical symptoms. Two researchers wrote six to eight items for each construct. Next, 18 experts rated 47 items based on their clarity, relevance, and representativeness. Pilot testing was carried out with 226 PLHIV in Spain. We retained 24 items based on empirical criteria that showed adequate psychometric properties. Confirmatory factor analysis confirmed the eight-factor structure with a good fit to the data (RMSEA = 0.035, AGFI = 0.97, CFI = 0.99). We found strong positive correlations between the instrument’s eight dimensions and validated measures of the same constructs. Likewise, we found negative associations between the dimensions of the CST-HIV and HRQoL. Conclusion The CST-HIV is a promising tool for use in routine clinical care to efficiently identify and address health-related issues undermining the HRQoL of PLHIV.
Article
Full-text available
The roles of immunodeficiency and combined antiretroviral therapy (cART) in shaping the gut microbiota in HIV-1-infected subjects (HISs) have not been described thoroughly by time-series investigations. In this study, 36 antiretroviral-naïve HISs were enrolled to prospectively assess alterations in the fecal microbiota and plasma markers of microbial translocation and inflammation with cART. At baseline, the species α-diversity of the fecal microbiota was significantly lower in HISs with a CD4+ T cell count <300/mm3 than in HISs with a CD4+ T cell count >300/mm3 (Shannon index: Median 2.557 vs. 2.981, P = 0.006; Simpson index: Median 0.168 vs. 0.096, P = 0.004). Additionally, the baseline α-diversity indices correlated with CD4+ T cell counts (Shannon index: r = 0.474, P = 0.004; Simpson index: r = −0.467, P = 0.004) and the specific plasma biomarkers for microbial translocation and inflammation. After cART introduction, the species α-diversity of fecal microbiota in HISs with CD4+ T cell counts <300/mm3 was significantly restored (Shannon index: Median 2.557 vs. 2.791, P = 0.007; Simpson index: Median 0.168 vs. 0.112, P = 0.004), while the variances were insignificant among HISs with CD4+ T cell counts >300/mm3 (Shannon index: Median 2.981 vs. 2.934, P = 0.179; Simpson index: Median 0.096 vs. 0.119, P = 0.082). Meanwhile, with cART introduction, alterations in the gut microbial composition were more significant in the subgroup with CD4+ T cell counts >300/mm3, corresponding to increases in the specific plasma inflammatory markers. These findings implicated the interactive roles of immunodeficiency and cART for affecting gut microbiota in HIV-1-infected individuals, providing new insights into intestinal microbiome dysbiosis related to HIV-1 infection.
Article
Full-text available
The aim of this study was to evaluate the nutritional status and gastrointestinal disorders of hospitalized patients with HIV/AIDS at the Hospital Universitário João de Barros Barreto (HUJBB) in Belém, Pará State, Brazil, attended from May to August 2014. The sample consisted of patients hospitalized in the Clinic for Infectious and Parasitic Diseases of HUJBB, both sexes, aged between 20 and 59 years old and anthropometric data were collected, such as body mass index (BMI), arm circumference (AC) and triceps skinfold (TSF); and gastrointestinal disorders (nausea, vomiting, diarrhea, abdominal distension and oral candidiasis). The sample consisted of 46 patients, mostly male and living in Belém. Malnutrition was found by checking BMI (54.3%), AC (78.3%) and TSF (91.3%). According to the gastrointestinal disorders reported by the patients with HIV/AIDS, it was observed that, in the study, most of them had nausea (54%), abdominal distention (52%) and vomiting (50%). A minority of patients, although significant ones, also reported the presence of diarrhea (46%) and oral candidiasis (46%). It is very common the presence of gastrointestinal symptoms in HIV-infected patients, mainly due to opportunistic diseases, which are the reasons for frequent hospitalization of these patients. The immediate nutritional assessment in this group of hospitalized patients is essential to diagnose possible risks of malnutrition and the presence of gastrointestinal symptoms that interfere in their nutritional status directly and early that are one of the reasons for hospitalizations.
Article
Full-text available
ABSTRACT: The American Academy of Sleep Medicine and Sleep Research Society recently released a Consensus Statement regarding the recommended amount of sleep to promote optimal health in adults. This paper describes the methodology, background literature, voting process, and voting results for the consensus statement. In addition, we address important assumptions and challenges encountered during the consensus process. Finally, we outline future directions that will advance our understanding of sleep need and place sleep duration in the broader context of sleep health.
Article
Full-text available
The objective of this review was to investigate the impact of shift and night work on metabolic processes and the role of alterations in the sleep-wake cycle and feeding times and environmental changes in the occurrence of metabolic disorders. The literature review was performed by searching three electronic databases for relevant studies published in the last 10 years. The methodological quality of each study was assessed, and best-evidence synthesis was applied to draw conclusions. The literature has shown changes in concentrations of melatonin, cortisol, ghrelin, and leptin among shift workers. Melatonin has been implicated for its role in the synthesis and action of insulin. The action of this hormone also regulates the expression of transporter glucose type 4 or triggers phosphorylation of the insulin receptor. Therefore, a reduction in melatonin can be associated with an increase in insulin resistance and a propensity for the development of diabetes. Moreover, shift work can negatively affect sleep and contribute to sedentarism, unhealthy eating habits, and stress. Recent studies on metabolic processes have increasingly revealed their complexity. Physiological changes induced in workers who invert their activity-rest cycle to fulfill work hours include disruptions in metabolic processes.
Article
Full-text available
Background: In patients with HIV, immune reconstitution after antiretroviral therapy (ART) is often incomplete. We assessed the probability of patients reaching a CD4/CD8 ratio of 1 or more after the start of ART and its association with the onset of non-AIDS-defining events and death. Methods: We did an analysis of the ICONA cohort, which recruited treatment-naive patients with HIV in Italy. We included participants in the cohort who started ART, reached an undetectable viral load (≤80 copies per mL), and had a CD4/CD8 ratio of less than 0·8 at the time of an undetectable viral load. We defined ratio normalisation in patients as two consecutive values of 1 or more. We used Kaplan-Meier curves to estimate the cumulative probability of ratio normalisation. We then used Poisson regression models to identify factors independently associated with normalisation and with progression to non-AIDS-defining events or death. Findings: We included 3236 participants, enrolled between Jan 22, 1997, and Feb 25, 2013. At the start of ART, median CD4/CD8 ratio in our population was 0·39 (IQR 0·26-0·55). 458 (14%) patients reached a CD4/CD8 ratio of 1 or more; the estimated probability of normalisation was 4·4% (95% CI 3·7-5·2) by 1 year from baseline, 11·5% (10·2-13·0) by 2 years, and 29·4% (26·7-32·4) by 5 years. Factors associated with normalisation were high pre-ART CD4 cell counts, a high CD4/CD8 ratio at baseline, and negative cytomegalovirus serological findings. The incidence rate of non-AIDS-defining events for patients with a CD4/CD8 ratio of less than 0·30 (4·2 per 100 patient-years, 95% CI 3·4-5·3) was double that for those with a ratio of 0·30-0·45 (2·3, 2·1-2·5) or more than 0·45 (2·2, 1·7-2·9). A ratio of less than 0·30 was independently associated with an increased risk of non-AIDS-defining events or death compared with one of more than 0·45. Interpretation: Few patients had normalised CD4/CD8 ratios, even though they had viral suppression. Low ratios were associated with increased risk of serious events and deaths. The CD4/CD8 ratio could be used by clinicians to identity patients at risk of non-AIDS-related events. Funding: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck Sharp & Dohme, ViiV Italy.
Article
Full-text available
Sleep is an essential lifestyle factor that contributes to overall health. The inverse relation between sleep duration and weight status has revealed the importance of sleep in nutritional health. This integrative review builds foundational knowledge with regard to sleep vis-à-vis nutrition by summarizing the importance and process of sleep, current sleep recommendations and trends, as well as lifestyle contributors to poor sleep. Additionally, it details the association between sleep and obesity and potential mechanisms for this association. Furthermore, guidance is offered regarding the incorporation of sleep considerations in nutrition counseling, communication, and research. Like many other lifestyle factors that contribute to nutritional health, sleep needs to be considered when examining weight management and health promotion.
Article
Full-text available
Introduction: Sleep disturbances are frequently reported in HIV-infected patients but there is a lack of large studies on prevalence and risk factors, particularly in the context of current improved immuno-clinical status and use of the newest antiretrovirals (ARV). Method: Cross-sectional study to evaluate the prevalence and factors associated with sleep disturbance in adult HIV-infected patients in six French centres of the region “Pays de la Loire”. Patients filled a self-administered questionnaire on their health behaviour, sleep attitudes (Pittsburgh Sleep Quality Index PSQI), quality of life (WHO QOL HIV BREF questionnaire) and depression (Beck depression Inventory (BDI)-II questionnaire). Socio-demographic and immunovirologic data, medical history, ARVs were collected. Results: From November 2012 to May 2013, 1354 consecutive non-selected patients were enrolled. Patients’ characteristics were: 73.5% male, median age 47 years, active employment 56.7%, France-native 83% and Africa-native 14.7%, CDC stage C 21%, hepatitis co-infection 13%, lipodystrophy 11.8%, dyslipidemia 20%, high BP 15.1%, diabetes 3%, tobacco smokers 39%, marijuana and cocaine users, 11.7% and 1.7% respectively, and excessive alcohol drinkers 9%. Median (med) duration of HIV infection was 12.4 years, med CD4 count was 604/mm3; 94% of Patients were on ARVs, 87% had undetectable viral load. Median sleeping time was 7 hours. Sleep disturbances (defined as PSQI score >5) were observed in 47% of the patients, more frequently in female (56.4%) than in male (43.9%) (p19) in 19.7% of the patients. In multivariate analysis, factors associated with sleep disturbances (p10 vs.
Article
Full-text available
Background: Human immunodeficiency virus (HIV)-infected individuals may be at increased risk of age-associated noncommunicable comorbidities (AANCCs). Methods: Cross-sectional analyses of AANCC prevalence (including cardiovascular, metabolic, pulmonary, renal, bone, and malignant disease) and risk factors in a prospective cohort study of HIV type 1-infected individuals and HIV-uninfected controls, who were aged ≥45 years and comparable regarding most lifestyle and demographic factors. Results: HIV-infected participants (n = 540) had a significantly higher mean number of AANCCs than controls (n = 524) (1.3 [SD, 1.14] vs 1.0 [SD, 0.95]; P < .001), with significantly more HIV-infected participants having ≥1 AANCC (69.4% vs 61.8%; P = .009). Hypertension, myocardial infarction, peripheral arterial disease, and impaired renal function were significantly more prevalent among HIV-infected participants. Risk of AANCC by ordinal logistic regression was independently associated with age, smoking, positive family history for cardiovascular/metabolic disease, and higher waist-to-hip ratio, but also with HIV infection (odds ratio, 1.58 [95% confidence interval, 1.23-2.03]; P < .001). In those with HIV, longer exposure to CD4 counts <200 cells/µL, and, to a lesser extent, higher levels of high-sensitivity C-reactive protein and soluble CD14, and longer prior use of high-dose ritonavir (≥400 mg/24 hours) were each also associated with a higher risk of AANCCs. Conclusions: All AANCCs were numerically more prevalent, with peripheral arterial, cardiovascular disease, and impaired renal function significantly so, among HIV-infected participants compared with HIV-uninfected controls. Besides recognized cardiovascular risk factors, HIV infection and longer time spent with severe immunodeficiency increased the risk of a higher composite AANCC burden. There was a less pronounced contribution from residual inflammation, immune activation, and prior high-dose ritonavir use.
Article
Background: HIV has become a chronic disease. Therefore, the mental health and sleep quality of people living with HIV/AIDS (PLWHA) have become increasingly important issues of concern. Purpose: To explore the sleep quality, depression, anxiety, and self-esteem of PLWHA and the correlation between sleep quality and various related mental-health factors. Methods: A cross-sectional, descriptive, correlational study was conducted at a medical center in southern Taiwan in 2013-2014. Data on the sleep quality, depression, anxiety, and self-esteem of 146 PLWHA cases were collected using a structural questionnaire (the Pittsburgh Sleep Quality Index, the Center for Epidemiologic Studies Depression Scale, Zung's Self-Administered Anxiety Scale, and Rosenberg Self-Esteem Scale). Results: Three-fifths (60.3%) of the cases had poor sleep quality, 50% were inclined toward depression, and 36.3% were inclined toward anxiety, indicating that sleep quality, depression, and anxiety levels in these cases were worse than the general population. Moreover, significant correlations were identified between poor sleep quality and the variables of depression (r = .40, p < .001) and anxiety (r = .53, p < .001). Multiple variate analysis revealed that older age, subjective feelings that HIV significantly influenced personal life, anxiety, and depression were all significant predictors of sleep quality. No significant correlations were found between CD4 (cluster of differentiation 4) lymphocyte count, HIV viral load, or receiving antiretroviral therapy and the variables of sleep quality, depression, anxiety, or self-esteem. Conclusions / implications for practice: About half of the PLWHA cases in the present study exhibited poor sleep quality and tendencies toward depression and anxiety. Moreover, sleep quality and mental health factors were found to be not correlated with CD4 lymphocyte count, HIV viral load, or receiving antiretroviral therapy. Therefore, early evaluation of the sleep quality and mental health of people living with HIV/AIDS is recommended in order to provide holistic care.
Article
Introduction: Nowadays, nutrition plays a key role in the treatment of people living with HIV/AIDS (PLHA), especially in the case of metabolic changes due to highly active antiretroviral therapy (HAART), which could be related to cardiovascular diseases (CVD). Objective: To describe the nutritional and clinical status and the quality of diet of PLHA. Methodology: A cross-sectional study was conducted with a network of outpatient care facilities for PLHA in the city of São Paulo, Brazil. The patients, undergoing HAART or not, were selected from December 2004 to May 2006, through routine clinic visits. The following were collected: Socio-demographic, clinical, biochemical and anthropometric measurements and dietary data. Diet quality was evaluated according to the scores of pattern of consumption, "protective" or "not protective" against CVD. Results: The sample included 238 patients undergoing HAART and 76 not undergoing it. Average serum levels of total cholesterol, triglycerides and glycemia were higher in the HAART group (p<0.001). The majority of patients of both groups undergoing HAART and not undergoing it were eutrophic, with an average body mass index (BMI) of 24.4 (±4.3) and 24.3 (±3.5) kg/m2, respectively. The waist-hip ratio was higher among men undergoing HAART than that in those not undergoing it (0.90±0.06 versus 0.87±0.05) (p<0.001). The group undergoing HAART showed a mean food pattern score that indicated a higher consumption of "not protective" foods against CVD (p=0,001). Conclusion: The results showed undesirable nutritional and metabolic conditions among patients undergoing HAART which were associated with CVD. Management of health interventions programs for PLHA is necessary to control cardiovascular risk factors before the outcome.